UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
$24M Class Action Settlement Reached with Teva Over Nexium Pay-for-Delay - Top Class Actions
Teva reaches $925,000 settlement to resolve drug price-fixing claims - PMLiVE
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva fueled opioid addiction in New York, jury finds | Crime | POST Online Media
💲420,000,000.00 Class Action Settlement | Deadline TEVA Stock News Money Stocks $TEVA Pharmaceutical - YouTube
Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel
Class Action Update - Claim Your Cash (December, 2019)
Is Teva on its Way to Losing its Trademark? - The Fashion Law
Teva settles investor lawsuit for $420m - Globes
Tentative $161.5 million settlement reached in opioid trial
Teva to pay $512M to resolve Provigil-delay lawsuit
Teva Shareholder Notice
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary
Rosen Law Firm Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
Teva settles investor lawsuit for $420m - Globes
